These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 10579141)

  • 1. Pharmacokinetic and pharmacodynamic consequences of metabolism-based drug interactions with alprazolam, midazolam, and triazolam.
    Yuan R; Flockhart DA; Balian JD
    J Clin Pharmacol; 1999 Nov; 39(11):1109-25. PubMed ID: 10579141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo comparisons of constitutive cytochrome P450 3A activity assessed by alprazolam, triazolam, and midazolam.
    Masica AL; Mayo G; Wilkinson GR
    Clin Pharmacol Ther; 2004 Oct; 76(4):341-9. PubMed ID: 15470333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketoconazole inhibition of triazolam and alprazolam clearance: differential kinetic and dynamic consequences.
    Greenblatt DJ; Wright CE; von Moltke LL; Harmatz JS; Ehrenberg BL; Harrel LM; Corbett K; Counihan M; Tobias S; Shader RI
    Clin Pharmacol Ther; 1998 Sep; 64(3):237-47. PubMed ID: 9757147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orally delivered alprazolam, diazepam, and triazolam as reinforcers in rhesus monkeys.
    Gomez TH; Roache JD; Meisch RA
    Psychopharmacology (Berl); 2002 Apr; 161(1):86-94. PubMed ID: 11967635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the anxiolytic and amnesic effects of three benzodiazepines, diazepam, alprazolam and triazolam, by conflict and non-matching to sample tests in mice.
    Kuribara H; Asahi T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1997 Feb; 17(1):1-6. PubMed ID: 9134532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alprazolam-ritonavir interaction: implications for product labeling.
    Greenblatt DJ; von Moltke LL; Harmatz JS; Durol AL; Daily JP; Graf JA; Mertzanis P; Hoffman JL; Shader RI
    Clin Pharmacol Ther; 2000 Apr; 67(4):335-41. PubMed ID: 10801241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic consequences of long term coadministration of cimetidine and triazolobenzodiazepines, alprazolam and triazolam, in healthy subjects.
    Pourbaix S; Desager JP; Hulhoven R; Smith RB; Harvengt C
    Int J Clin Pharmacol Ther Toxicol; 1985 Aug; 23(8):447-51. PubMed ID: 2864320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro, pharmacokinetic, and pharmacodynamic interactions of ketoconazole and midazolam in the rat.
    Kotegawa T; Laurijssens BE; Von Moltke LL; Cotreau MM; Perloff MD; Venkatakrishnan K; Warrington JS; Granda BW; Harmatz JS; Greenblatt DJ
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1228-37. PubMed ID: 12183684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between midazolam and clarithromycin: comparison with azithromycin.
    Yeates RA; Laufen H; Zimmermann T
    Int J Clin Pharmacol Ther; 1996 Sep; 34(9):400-5. PubMed ID: 8880291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerance to the anxiolytic effects of the triazolobenzodiazepines triazolam and alprazolam, as measured by the ingestion of a hypertonic sodium chloride solution in rats.
    Barbarito EJ; Lau CE; Falk JL
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1201-8. PubMed ID: 8819503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Separate evaluation of intestinal and hepatic metabolism of three benzodiazepines in rats with cannulated portal and jugular veins: comparison with the profile in non-cannulated mice.
    Kuze J; Mutoh T; Takenaka T; Morisaki K; Nakura H; Hanioka N; Narimatsu S
    Xenobiotica; 2009 Nov; 39(11):871-80. PubMed ID: 19845438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the pharmacokinetic interaction of midazolam with ursodeoxycholic acid, ketoconazole and dexamethasone by brain benzodiazepine receptor occupancy.
    Misaka S; Kurosawa S; Uchida S; Yoshida A; Kato Y; Kagawa Y; Yamada S
    J Pharm Pharmacol; 2011 Jan; 63(1):58-64. PubMed ID: 21155816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P450 3A4 in vivo ketoconazole competitive inhibition: determination of Ki and dangers associated with high clearance drugs in general.
    Boxenbaum H
    J Pharm Pharm Sci; 1999; 2(2):47-52. PubMed ID: 10952769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coadministration of nefazodone and benzodiazepines: I. Pharmacodynamic assessment.
    Kroboth PD; Folan MM; Lush RM; Chaikin PC; Shukla UA; Barbhaiya R; Salazar DE
    J Clin Psychopharmacol; 1995 Oct; 15(5):306-19. PubMed ID: 8830061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics, pharmacodynamics, and treatment issues of benzodiazepines: alprazolam, adinazolam, and clonazepam.
    DeVane CL; Ware MR; Lydiard RB
    Psychopharmacol Bull; 1991; 27(4):463-73. PubMed ID: 1687613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic and pharmacodynamic interaction study between midazolam and the macrolide antibiotics, erythromycin, clarithromycin, and the azalide azithromycin.
    Yeates RA; Laufen H; Zimmermann T; Schumacher T
    Int J Clin Pharmacol Ther; 1997 Dec; 35(12):577-9. PubMed ID: 9455717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of correlation between in vitro and in vivo studies on the effects of tangeretin and tangerine juice on midazolam hydroxylation.
    Backman JT; Mäenpää J; Belle DJ; Wrighton SA; Kivistö KT; Neuvonen PJ
    Clin Pharmacol Ther; 2000 Apr; 67(4):382-90. PubMed ID: 10801247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacology of alprazolam: a review.
    Huybrechts I
    Clin Ther; 1991; 13(1):100-17. PubMed ID: 2029716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and pharmacodynamic evaluation of the inhibition of alprazolam by citalopram and fluoxetine.
    Hall J; Naranjo CA; Sproule BA; Herrmann N
    J Clin Psychopharmacol; 2003 Aug; 23(4):349-57. PubMed ID: 12920410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of different durations of ketoconazole dosing on the single-dose pharmacokinetics of midazolam: shortening the paradigm.
    Stoch SA; Friedman E; Maes A; Yee K; Xu Y; Larson P; Fitzgerald M; Chodakewitz J; Wagner JA
    J Clin Pharmacol; 2009 Apr; 49(4):398-406. PubMed ID: 19246722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.